Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction.
about
The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic reviewXanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts.Modular organization of cardiac energy metabolism: energy conversion, transfer and feedback regulation.Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun.G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium.Metabolic flux as a predictor of heart failure prognosis.Cardiac structure and function during ageing in energetically compromised Guanidinoacetate N-methyltransferase (GAMT)-knockout mice - a one year longitudinal MRI study.Energy metabolism in heart failure and remodelling.Myocardial energetics in heart failure.Role of the phosphocreatine system on energetic homeostasis in skeletal and cardiac muscles.Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.Metabolic remodelling in hypertrophied and failing myocardium: a review.Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved.Synergistic role of ADP and Ca(2+) in diastolic myocardial stiffness.Modeling of spatial metabolite distributions in the cardiac sarcomere.
P2860
Q26822632-C2988CC9-0E6B-4AF0-BDD2-0116BEA9B161Q31007181-40DEC9C4-92DD-4B92-B712-9CCA16B6C173Q34253138-42B8E8B0-8A5F-4C02-9511-46906D5F782AQ34275695-438E8A42-2501-45F9-953F-128850701A27Q34760678-4049D550-D405-415E-9FAB-09F0DC5AE34DQ35041039-3361F8EE-3B88-45CF-8A22-471FF0404AC6Q35659510-31BB3FD6-F554-4CEE-BF90-0D1896BFE24AQ36015240-4525FF44-C311-466E-8B78-139B08F4EE76Q36478149-85944C86-E2F1-4FAF-AF09-F2B93A75B38FQ37090565-BF83DB67-8DF7-4FF2-9D77-11C85D9A248CQ38112349-9BF6340D-EB42-4E91-B3BB-74D96CF46336Q38204256-3C1DF120-1FC5-4F5B-8436-8C15855E0460Q38706110-FC4A77C3-43A1-4DD0-A3B7-59537990E5BEQ39395331-47241F44-ADE8-4BCE-A753-888E78D3779FQ40053312-8485B5D7-D329-422B-A9CD-AD9A7DB9A7F4Q42478668-EAB000AA-CBF2-451C-A63F-798ED76F073AQ42850661-16B93865-D689-4F89-A004-DE2272A566E5
P2860
Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@en
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@nl
type
label
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@en
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@nl
prefLabel
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@en
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@nl
P2093
P356
P1433
P1476
Chronic phosphocreatine deplet ...... s after myocardial infarction.
@en
P2093
P304
P356
10.1161/HC3901.095933
P407
P577
2001-10-01T00:00:00Z